ISSN: 0312-5963
Journal Home
Journal Guideline
Clinical Pharmacokinetics Q1 Unclaimed
Clinical Pharmacokinetics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 184. It has a price of 3290 €. It has an SJR impact factor of 1,125 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,125.
Clinical Pharmacokinetics focuses its scope in these topics and keywords: pharmacokinetics, pharmacodynamics, subjects, metastatic, lmethyltetrahydrofolateclinical, intramuscular, interactions, ii, ideal, healthy, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3290 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,125
SJR Impact factor184
H Index125
Total Docs (Last Year)363
Total Docs (3 years)5322
Total Refs1577
Total Cites (3 years)335
Citable Docs (3 years)4.09
Cites/Doc (2 years)42.58
Ref/DocOther journals with similar parameters
Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1
Compare this journals
Aims and Scope
Best articles by citations
Pharmacokinetic Individualisation of Zidovudine Therapy
View moreA Retrospective Analysis of Pharmacokinetic-Pharmacodynamic Parameters as Indicators of the Clinical Efficacy of Ceftizoxime
View morePharmacokinetic Interactions of Antimalarial Agents
View morePopulation Pharmacokinetics of??Levetiracetam in Japanese and??Western Adults
View moreEffect of Rifampicin on the Pharmacokinetics of Fluconazole in Patients with AIDS
View morePharmacokinetic Optimisation in the Treatment of Gastro-Oesophageal Reflux Disease
View moreGuidelines on Paediatric Dosing on the Basis of Developmental Physiology and Pharmacokinetic Considerations
View morePharmacokinetic Optimisation of Antibacterial Treatment in Patients with Cystic Fibrosis
View moreIntracellular Concentrations of Antibacterial Agents and Related Clinical Implications
View morePharmacokinetic Optimisation of Oral Antifungal Therapy
View moreAnimal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine
View morePharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System Infections
View moreStrategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism
View moreDosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy
View moreApplication of a Gamma Model of Absorption to Oral Cyclosporin
View moreRelationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive Patients
View moreEvaluation of Pharmacokinetic Interactions After Oral Administration of Mycophenolate Mofetil and Valaciclovir or Aciclovir to Healthy Subjects
View moreRelationship Between Minimum Inhibitory Concentration and Stationary Concentration Revisited
View morePharmacokinetic Study of Tacrolimus in Cystic Fibrosis and Non-Cystic Fibrosis Lung Transplant Patients and Design of Bayesian Estimators Using Limited Sampling Strategies
View moreAuthors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"
View moreOsmotherapy for Elevated Intracranial Pressure
View moreDosage Adjustments for Antibacterials in Obese Patients
View moreSize, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients
View moreComparative Pharmacokinetics and Pharmacodynamics of the Newer Fluoroquinolone Antibacterials
View more
Comments